Skip to main content
Home » Reports » Healthcare » ADME Toxicology Testing Market
ReesrachMoz Brochure Icon

Global ADME Toxicology Testing Market Analysis and Forecast 2021-2026

Report ID:606Healthcare215 pages

ADME Toxicology Testing Market Statistics

The global ADME toxicology testing market is expected to grow at a CAGR of 11.4% from 2021 to 2026, previously it grew at 13% from 2015 to 2020.

The increasing prevalence of chronic diseases is expected to drive the global ADME market in the coming years.

The ADME toxicology tests are usually carried out the biomedical researchers in cell-based and in-vitro assays, with the help of software solutions, detectors, devices, etc. in order to identify active compounds, biomolecular interactions, and genetic interactions.

Amid covid pandemic, the global ADME toxicology testing market is expected to flourish in the coming years, covid had a positive impact on the market.

Drivers and Restraints

The rising demand for drug development in order to target treat chronic diseases is expected to drive the global ADME toxicology testing market during the forecast years.

The increasing focus on drug safety and efficacy in drug components which is further subject to FDA and other regulatory approvals is anticipated to bolster the demand for ADME toxicology in the coming years.

Increasing demand for novel drugs and biological products is expected to drive the global ADME toxicology testing market in the following years.

The surge in the investment by government and private sectors for advanced healthcare facilities is foreseen to augment the growth of the global ADME toxicology during the forecast period.

FDA has put forth certain guidelines such as safety testing of drug metabolites, in vitro metabolism, transporter-mediated drug studies, etc are expected to bolster the demand for ADME toxicology testing.

However, the stringent rules and high cost associated with the testing are expected to dampen the global ADME toxicology testing market during the forecast period.

Nonetheless, growing research and development in concurrence with technological advancement, thus resulting in the expansion of the global ADME toxicology testing market in the following years.

Global ADME Toxicology Testing Market Share By Region Type

Opportunities and Trends

The rising awareness among patients with regard to the benefits of the ADME Toxicology market is projected to boost growth opportunities in the global ADME toxicology market during the forecast period.

The increase in drug failures is expected to push the expansion opportunities for the global ADME toxicology testing market in the following years.

The need for checking the viability of drug candidates to seek approvals is anticipated to augment the global ADME toxicology.

The rising trend in the chronic diseases is expected to nudge the growth in the global ADME toxicology testing market in the following years.

Product Segment

The global ADME Toxicology market is segmented into various categories such as technology, product type, end users, and application.

On the basis of technology, the global ADME toxicology testing market is further divided into- Cell culture, High throughput screening, molecular imaging, OMICS technology, and others.

Among these, the cell culture is expected to thrive in the global ADME toxicology testing market, owing to this method being highly preferred by the researchers.

On the basis of application type, the global ADME toxicology testing market is further segmented into systemic toxicity, hepatotoxicity, renal toxicity, neurotoxicity, and others.

On the basis of product type, the ADME toxicology testing market is bifurcated into software solutions, reagents, assays systems, and others.

Of these, both software solutions and assays system are expected to dominate the market simultaneously, during the forecast period.

In terms of end users, the global ADME toxicology testing market is segmented into food industry, animal industry, cosmetics & households’ goods, pharmaceuticals industry, and others.

Here, the pharmaceuticals are expected to bolster the demand in the ADME toxicology testing market in the following years.

Regional Overview

In terms of region, the global ADME toxicology testing market is expected to be dominated by Asia Pacific during the forecast period, owing to increasing research on pharmaceutical molecules and growing adoption of advancement in the technology for drug development.

Alternatively, North America is expected to augment in the global ADME toxicology testing market, owing to rising technological advances, increasing healthcare facilities in the region.

It was North America which dominated the global ADME toxicology testing market previously, owing to technological advancement.

Competitive Landscape

The global ADME toxicology testing market is intensely competitive with the presence of many players. The players are applying various organic and inorganic strategies to penetrate into the market.

Further, the players in the market are focusing more on research and development activities to improve the product quality and the portfolio to penetrate deeper into the global ADME toxicology testing market in the following years.

Many companies are adopting precise toxicity methodologies to reduce the cost and be specific with the target findings, this even saves time, owing to the expansion of the global ADME toxicology testing market.

The prominent plyers in the global ADME toxicology testing market include-

  • Agilent Technologies, Inc.
  • Albany Molecular Research Inc.
  • Accelrys Inc.
  • Actelion Pharmaceuticals
  • AbbVie
  • Beckman Coulter Inc.
  • Charles River Laboratories International Inc.
  • Catalent Inc.

Product Disposition (USD Revenue in Millions)

  • Software Solutions
  • Assays Systems
  • Reagents

Applications Disposition (USD Revenue in Millions)

  • Systemic Toxicity
  • Hepatotoxicity
  • Renal Toxicity
  • Neurotoxicity
  • Others

End Users Disposition (USD Revenue in Millions)

  • Food industry
  • Animal industry
  • Cosmetics & households’ goods
  • Pharmaceuticals Industry
  • Others

Regional Disposition         

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions-

  1. What are the challenges in the global ADME toxicology testing market?
  2. What will cause the market to expand during the forecast period?
  3. Which region will dominate in the global ADME toxicology testing market?
  4. What are the available opportunities in the ADME toxicology testing market?
  5. What are product and end users’ segment that would thrive in the global ADME toxicology testing market?
  6. How would the competitors strengthen their positions in the global ADME toxicology testing market in the coming years?
  7. How well would the ADME toxicology testing market grow during the forecast period?

Table Of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global ADME Toxicology Testing Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

5. Global ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Disposition
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Disposition, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Disposition, 2022-2032
5.3.1. Software Solutions
5.3.2. Assays Systems
5.3.3. Reagents
5.4. Y-o-Y Growth Trend Analysis By Product Disposition, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Disposition, 2022-2032

6. Global ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Applications Disposition
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Applications Disposition, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Applications Disposition, 2022-2032
6.3.1. Systemic Toxicity
6.3.2. Hepatotoxicity
6.3.3. Renal Toxicity
6.3.4. Neurotoxicity
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By Applications Disposition, 2017-2021
6.5. Absolute $ Opportunity Analysis By Applications Disposition, 2022-2032

7. Global ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End Users Disposition
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End Users Disposition, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End Users Disposition, 2022-2032
7.3.1. Food industry
7.3.2. Animal industry
7.3.3. Cosmetics & households’ goods
7.3.4. Pharmaceuticals Industry
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By End Users Disposition, 2017-2021
7.5. Absolute $ Opportunity Analysis By End Users Disposition, 2022-2032

8. Global ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region

9. North America ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Disposition
9.2.3. By Applications Disposition
9.2.4. By End Users Disposition
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Disposition
9.3.3. By Applications Disposition
9.3.4. By End Users Disposition
9.4. Key Takeaways

10. Latin America ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Product Disposition
10.2.3. By Applications Disposition
10.2.4. By End Users Disposition
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Disposition
10.3.3. By Applications Disposition
10.3.4. By End Users Disposition
10.4. Key Takeaways

11. Europe ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Disposition
11.2.3. By Applications Disposition
11.2.4. By End Users Disposition
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Disposition
11.3.3. By Applications Disposition
11.3.4. By End Users Disposition
11.4. Key Takeaways

12. East Asia ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Disposition
12.2.3. By Applications Disposition
12.2.4. By End Users Disposition
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Disposition
12.3.3. By Applications Disposition
12.3.4. By End Users Disposition
12.4. Key Takeaways

13. South Asia ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Product Disposition
13.2.3. By Applications Disposition
13.2.4. By End Users Disposition
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Disposition
13.3.3. By Applications Disposition
13.3.4. By End Users Disposition
13.4. Key Takeaways

14. Oceania ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Disposition
14.2.3. By Applications Disposition
14.2.4. By End Users Disposition
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Disposition
14.3.3. By Applications Disposition
14.3.4. By End Users Disposition
14.4. Key Takeaways

15. MEA ADME Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Product Disposition
15.2.3. By Applications Disposition
15.2.4. By End Users Disposition
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Disposition
15.3.3. By Applications Disposition
15.3.4. By End Users Disposition
15.4. Key Takeaways

16. Key Countries ADME Toxicology Testing Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product Disposition
16.1.2.2. By Applications Disposition
16.1.2.3. By End Users Disposition
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product Disposition
16.2.2.2. By Applications Disposition
16.2.2.3. By End Users Disposition
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product Disposition
16.3.2.2. By Applications Disposition
16.3.2.3. By End Users Disposition
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product Disposition
16.4.2.2. By Applications Disposition
16.4.2.3. By End Users Disposition
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product Disposition
16.5.2.2. By Applications Disposition
16.5.2.3. By End Users Disposition

17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1.  By Regional
17.3.2.  By Product Disposition
17.3.3.  By Applications Disposition
17.3.4.  By End Users Disposition

18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Agilent Technologies, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Albany Molecular Research Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Accelrys Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Actelion Pharmaceuticals
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. AbbVie
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Beckman Coulter Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Charles River Laboratories International Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Catalent Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Request Free Sample

Hidden
Company logos Strips